Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Carnitine, valproate, and toxicity.

¹Department of Pediatrics, Boston University School of Medicine, MA.

Journal of Child Neurology

|January 1, 1991

Summary

This summary is machine-generated.

Carnitine deficiency, linked to valproate therapy, may affect fatty acid metabolism and mitochondrial function. Monitoring carnitine levels is crucial in children with neurological issues on antiepileptic drugs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Morfeo Study: A 1-year follow-up of complications of vegetative state in a dedicated facility.

Brain injury·2010

Same author

L-carnitine supplementation in childhood epilepsy: current perspectives.

Epilepsia·1998

Same author

Effectiveness and cost of generic versus brand-name valproic acid.

Mental retardation·1998

Same author

Comprehensive management of epilepsy in persons with mental retardation.

Epilepsia·1997

Same author

Prevention as a form of support: implications for the new definition.

Mental retardation·1996

Same author

Carnitine deficiency in epilepsy: Risk factors and treatment.

Journal of child neurology·1995

Same journal

Birmingham, 1963.

Journal of child neurology·2026

Same journal

Hyperintensity on Diffusion-Weighted Imaging in a MELAS Patient Does Not Necessarily Mean Cytotoxic Edema.

Journal of child neurology·2026

Same journal

Neuromuscular Symptoms of <i>ORAI1</i>-Related Immunodeficiency.

Journal of child neurology·2026

Same journal

Symptoms of Obsessive-Compulsive Disorder, Attention-Deficit/Hyperactivity Disorder, and Autism Spectrum Disorder in Children and Adolescents Attending a Headache Outpatient Clinic and School-Based Controls.

Journal of child neurology·2026

Same journal

Acute Encephalopathy From Central Nervous System Hemophagocytic Lymphohistiocytosis (CNS HLH) in X-Linked Lymphoproliferative Disease Type 1 (XLP-1).

Journal of child neurology·2026

Same journal

The Cost of Fear for Pediatric Neurologic Care.

Journal of child neurology·2026

See all related articles

Area of Science:

Nutritional Biochemistry
Mitochondrial Metabolism

Background:

Carnitine is essential for long-chain fatty acid metabolism and mitochondrial function.
Dietary intake and endogenous synthesis contribute to carnitine levels.
Carnitine deficiency can arise from genetic disorders, nutritional deficits, or certain medications.

Purpose of the Study:

To review the role of carnitine in metabolism.
To examine the association between valproate therapy and carnitine deficiency.
To assess the implications of carnitine deficiency and supplementation.

Main Methods:

Literature review of experimental and clinical studies.
Analysis of existing data on carnitine levels during valproate therapy.
Evaluation of evidence linking carnitine deficiency to hepatotoxicity.

Related Experiment Videos

Main Results:

Valproate therapy is frequently associated with reduced carnitine levels, sometimes leading to deficiency.
Limited evidence suggests a potential link between valproate-induced carnitine deficiency and liver toxicity.
Carnitine supplementation shows some benefit in limited studies.

Conclusions:

Carnitine deficiency is a concern in patients on valproate, particularly those with neurological conditions.
Measurement of carnitine levels is recommended for at-risk patients.
Further research is needed to clarify the link between valproate, carnitine deficiency, and hepatotoxicity.